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Objective To evaluate the burden and predictors of hospital readmissions among pediatric patients with inflam-
matory bowel disease using the Nationwide Readmissions Database.
Study design We performed a retrospective cohort study using 2013 Nationwide Readmissions Database. In-
ternational Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify patients <18
years with diagnoses of ulcerative colitis (UC) or Crohn’s disease (CD). Demographic factors and details of hos-
pitalizations were evaluated using survey procedures in SAS v 9.4 (SAS Institute, Cary, North Carolina). Multivari-
able logistic regression was used to estimate ORs and 95% CIs of readmission.
Results Among 2733 hospitalizations (63% CD, 37% UC), 611 (22%) patients were readmitted within 90 days of
the index hospitalization. Readmission resulted in weighted estimates of 11 440 excess days of hospitalization and
total charges of over $107 million. For CD, male sex (aOR 1.36, 95% CI 1.03-1.81) and co-existing anxiety or de-
pression (aOR 1.89, 95% CI 1.06-3.40) were associated with increased readmissions, while patients who under-
went surgery had decreased readmissions (aOR 0.40, 95% CI 0.24-0.65). In patients with UC, an index admission
of >7 days was associated with increased readmissions (aOR 1.69, 95% CI 1.09-2.62).
Conclusions Readmission occurs frequently in children with inflammatory bowel disease and is associated with
significant cost and resource burdens. Among patients with CD, psychiatric comorbidities such as anxiety and de-
pression are apparent drivers of readmission. (J Pediatr 2017;191:184-9).
H ospital readmissions are a key metric associated with quality of healthcare in the US, with the potential to place a greatburden on both the patient and the healthcare system.1 Recent studies indicate that hospitalizations are increasing forchildren with inflammatory bowel diseases (IBD) in the US.2,3 In addition, a Canadian study demonstrated that pe-
diatric patients with IBD are at greater risk for hospital readmission compared with older patients.4 These trends are cause for
concern to both patients and payers, as hospitalization of pediatric patients with IBD has been associated with a significant
cost burden5-7 and hospitalization has been associated with decreased health-related quality of life in other populations of chil-
dren with chronic diseases.8
Despite these concerns, there remains a paucity of literature examining the factors associated with hospital readmissions in
children with Crohn’s disease (CD) and ulcerative colitis (UC). Studies of postsurgical readmissions in children with IBD in-
dicate that surgery performed by a pediatric surgeon9 and having surgery at a high volume hospital10 confer a lower risk of
postoperative readmission. However, the exact role that healthcare disparities, racial differences in phenotypes, or other con-
founding factors play in these risks for readmission is uncertain.11 Single center experiences from American adults with IBD
suggest that factors such as severe disease, poorly controlled pain and depression, and admission to a teaching service are as-
sociated with a higher likelihood of readmission,9-11 but it is unknown if these same factors are important in children with IBD.
Our objectives were to use the Nationwide Readmissions Database (NRD) to describe the overall burden of readmission in
patients with IBD, including the total charges associated with readmission, and analyze the specific factors associated with hos-
pital readmission within 90 days.
Methods
We conducted a retrospective cohort study using 2013 data from the NRD, a re-
source of the Healthcare Cost and Utilization Project (HCUP) State Inpatient
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Databases. Designed to be nationally representative in the adult
population, the NRD is a publicly available all-payer inpa-
tient database from the US that contains discharge data from
22 geographically dispersed states accounting for 49.3% of all
US hospitalizations. Weights were assigned to each admis-
sion by HCUP to allow for national readmission analyses. The
NRD contains over 100 clinical and nonclinical variables,12 in-
cluding outcomes such as hospital length of stay (LOS), re-
admission, and total charges. The NRD also contains up to 15
diagnostic and procedure codes per admission based on
International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) coding. This study was determined
exempt from review by the University of North Carolina
Institutional Review Board, given the deidentified nature of
the data.
We examined discharge data from patients age 17 years and
younger. Patients were determined to have IBD if they had a
primary or secondary ICD-9-CM diagnosis code indicating CD
(555.xx) or UC (556.xx) on the index admission. Given that
patients with UC undergoing colectomy could have a sched-
uled readmission for repeat operation such as ileal pouch-
anal anastomosis within the 90 day follow-up for readmission,
we excluded any patient with an ICD-9-CM code for colec-
tomy. Approximately 1% of patients were given discharge codes
for both CD and UC (n = 28), and to minimize misclassification
of subgroups of IBD, we excluded those patients.
The primary outcome of interest, hospital readmission within
90 days of the index hospitalization, was determined using a
unique identifier specific to the NRD to link discharge data
of individual patients. We also evaluated the primary ICD-9-
CM diagnosis code on readmission, LOS during all hospital-
izations, and the total charges associated with readmission.
Patient demographics included age, sex, and primary
insurance/payer for the index hospitalization. We used ICD-
9-CM diagnosis codes to identify additional comorbidities or
factors suggested to be independent predictors or confound-
ers of the relationship between IBD and hospital readmis-
sion. Given prior suggestions in adult populations that
modifiable risk factors such as depression (ICD-9-CM 296.2,
296.3, 298.0, 300.4, 311), chronic pain (338.2, 338.4), and
anxiety (300, 300.2) play a significant role in risk for read-
mission we made the a priori decision to include these
covariates in our analyses. We used ICD-9-CM definitions for
anxiety and depression that have previously been validated in
IBD using administrative data.13 In addition, the diagnosis
coding used to identify admissions with Clostridium difficile
infection (ICD-9-CM 008.45) has previously been used in
HCUP databases.14 IBD-related surgery was included in the
models for CD only. For patients with CD, ICD-9-CM coding
was used to identify potential complications of CD including
small bowel obstruction and fistulizing disease (ICD-9-CM
codes listed in Table I; available at www.jpeds.com).
In the NRD, hospital teaching status is defined as “metro-
politan teaching,” “metropolitan nonteaching,” and “rural.”
HCUP defines an institution as a teaching hospital if it has an
American Medical Association-approved residency program,
if the institution is a member of the Council of Teaching
Hospitals, or based on the ratio of full-time equivalent interns
and residents to hospital beds (0.25 or higher).12 In other HCUP
databases such as the Nationwide Inpatient Sample and the
Kids’ Inpatient Database, approximately 98% of patients with
IBD admitted to rural hospitals are admitted to nonteaching
hospitals,15 and HCUP indicates that rural teaching hospitals
are rare.12 For our analyses, we collapsed rural and metropoli-
tan nonteaching into 1 category and refer to metropolitan teach-
ing hospitals as “teaching.” We also analyzed hospitals based
on annual volume of patients with IBD, using thresholds pre-
viously established in the Kids’ Inpatient Database,7 where those
hospitals with an annual volume of IBD discharges of >20 were
defined as high volume IBD centers.
Statistical Analyses
All analyses were performed using survey procedures in SAS
v 9.4 (SAS Institute, Cary, North Carolina). Data were weighted
to reflect estimates of the national population, including the
means and proportions presented. The c2 test and Student t
test were used to compare proportions and continuous vari-
ables, respectively. We used logistic regression modeling to es-
timate the unadjusted odds of a readmission within 90 days
of the index hospitalization for the covariates of interest. In
all logistic regression models, we made the a priori decision
to include only patients with Medicaid (33% of all admis-
sions) or private insurance (60% of all admissions) as their
primary payer for the admission, given concerns that there may
be significant overlap between the “other” insurance pro-
vider group and the Medicaid group. In prespecified sensitiv-
ity analyses, we included all patients, regardless of payer status,
to assess for any differences in outcomes when patients with
other payers were included.
Based on clinical knowledge and previously reported risk
factors for readmission among adult populations of patients
with IBD, we then evaluated the association between risk factors
and readmission within 90 days using multivariable logistic
regression. All factors included in the models were chosen due
to their clinical relevance and were identified a priori, includ-
ing payer and hospital specific factors. For all analyses, diag-
noses of anxiety or depression were collapsed into one variable.
Any covariate with <11 patients was excluded from the mul-
tivariable models. ORs and 95% CIs are presented. A 2-tailed
P value of .05 was chosen as the threshold for statistical sig-
nificance for all tests.
Results
A total of 2733 (63% CD, 37% UC) patients with IBD were
identified in the NRD, of which 611 (22%) required readmis-
sion within 90 days of the index hospitalization. Using the NRD
weighting, these represented 8632 nationwide admissions and
1845 nationwide readmissions among pediatric patients with
IBD in 2013. Hospital readmission resulted in an additional
3788 days of hospitalization for those affected, representing
a weighted estimate of 11 440 excess days in the national
population of patients with IBD. Among patients with CD,
the median LOS for the first readmission was 3.69 days
(IQR1.95-6.58) compared with a median LOS of 4.53 days (IQR
2.41-8.84) for patients with UC (P = .057). Among patients with
CD requiring readmission, 85% had a diagnosis of CD as a
primary diagnosis. The other most common primary or sec-
ondary diagnoses on readmission among patients with CD were
anemia (3.3%), abnormal loss of weight (2%), dehydration
(1.5%), and C difficile infection (0.6%). Among patients with
UC requiring readmission, 89% had UC as a primary diag-
nosis. The other most common primary or secondary diagnoses
on readmission among patients with UC were anemia (13%),
abnormal loss of weight (5.1%), C difficile infection (2.5%),
and dehydration (2.5%). All ICD-9-CM codes for comorbid
diagnoses are listed in Table I.
The baseline demographics of the CD and UC popula-
tions are depicted in Table II. There was no significant dif-
ference in readmission if the diagnosis of CD was listed as the
primary or secondary diagnosis (22% vs 17%, P = .105). Al-
though the raw percentage of patients with a primary diag-
nosis of UC requiring readmission was also greater than that
of patients with a secondary diagnosis of UC, there was no sta-
tistically significant difference in readmission within 90 days
(25% vs 17%, P = .066).
Among patients with IBD who were readmitted within
90 days, the median total charges for the first readmission
were $31 282 (IQR $16 491-$62 496). There was no signifi-
cant difference when comparing the median total charges
for the first readmission in patients with UC to patients with
CD ($33 712 vs $30 387, P = .270). When aggregated among
all pediatric patients with IBD in the NRD, the total charges
attributed to the first readmission within 90 days were
$35 698 897 with a weighted estimate of $107 820 643 in the
national population of pediatric patients with IBD. Among
readmissions of patients with CD, 78% were identified as
nonelective readmissions. Sixty-seven percent of patients with
UC requiring readmission were reported to have a nonelec-
tive readmission.
Factors Associated with Readmission in CD
In univariate analysis of patients with CD, those patients re-
quiring readmission were more likely to be male, have a pre-
existing psychiatric diagnosis of anxiety or depression (Figure;
available at www.jpeds.com), and were less likely to have un-
dergone an IBD related surgery during the index admission
(Table III). There was no significant difference in readmission
Table II. Baseline clinical and demographic character-





n % n %
Age (y)
≤12 451 26 416 42
13-17 1282 74 684 68
Male sex 979 56 497 50
Anxiety or depression 101 6 43 4
Chronic pain <11 1 <11 1
Teaching hospital on index
admission
1549 89 869 87
Hospital volume on index
admission
≤20 IBD admissions per y 459 28 302 31
>20 IBD admissions per y 1274 72 698 69
Payer/insurance
Medicaid 549 32 375 38
Private insurance 1065 61 575 58
Other 119 7 78 8
C difficile infection 87 5 67 7
Need for IBD-related surgery 225 13 N/A N/A
LOS for index admission (d)
≤3 796 46 390 39
4-7 597 34 353 35
>7 340 20 257 26
Presence of a fistula 60 3 N/A N/A
Small bowel obstruction 226 13 N/A N/A
Table III. Univariate comparison of characteristics of pediatric patients with CD in the 2013 NRD, including unad-






(95% CI) P value
n % n %
Age (y) .183
≤ 12 371 27 80 22 Reference
13-17 993 73 289 78 1.22 (0.88-1.70)
Male sex 756 55 223 60 1.33 (1.01-1.75) .004
Anxiety or depression 73 5 28 8 1.99 (1.15-3.45) .028
Index admission to teaching hospital 1208 88 341 92 1.35 (0.85-2.14) .206
Index admission to high volume IBD center 980 72 294 74 1.12 (0.80-1.55) .509
Payer/insurance .087
Medicaid 414 30 135 37 1.28 (0.97-1.69)
Private insurance 857 63 208 56 Reference
C difficile infection 61 5 26 7 1.50 (0.87– 2.57) .200
Need for IBD-related surgery 196 14 29 8 0.49 (0.31-0.78) .003
LOS for index hospitalization (d) .057
≤3 640 47 156 42 0.83 (0.60-1.13)
4-7 471 35 126 34 Reference
>7 253 19 87 24 1.22 (0.84-1.76)
Presence of a fistula 48 4 12 3 0.84 (0.38-1.88) .754
Small bowel obstruction 173 13 53 14 1.33 (0.88-2.02) .067
if the diagnosis of CD was listed as the primary or secondary
diagnosis (22% vs 17%, P = .105). In multivariable analysis,
male sex (aOR 1.36, 95% CI 1.03-1.81) and co-existing anxiety
or depression (aOR 1.89, 95% CI 1.06-3.40) were associated
with a significant increase in odds of readmission within 90
days of index hospitalization (Table IV). In addition, the need
for IBD related surgery was associated with decreased odds of
readmission within 90 days (aOR 0.40, 95% CI 0.24-0.65). In
the prespecified sensitivity analysis including all payer sources,
there was no change in the final results.
Factors Associated with Readmission in UC
In univariate analysis, patients with UC requiring readmis-
sion were more likely to be admitted to teaching hospitals,
more likely to be admitted to high volume IBD centers, and
demonstrated longer LOS on the index admission when
compared with patients who did not require readmission
(Table V). When patients with UC were evaluated in multi-
variable analysis, only a LOS of >7 days during the index ad-
mission was associated with an increased odds of readmission
within 90 days (aOR 1.69, 95% CI 1.09-2.62, Table IV). Al-
though not significant, an increased odds of readmission within
90 days was suggested with a comorbid condition of anxiety
or depression (aOR 1.57, 95% CI 0.69-3.54), index admis-
sion to a teaching hospital (aOR 1.32, 95% CI 0.74-2.37), and
index admission to a high volume IBD center (aOR 1.27, 95%
CI 0.84-1.69). A sensitivity analysis was also performed in-
cluding all payer sources, which demonstrated no change in
the final results.
Discussion
Based on this US nationwide study of pediatric patients with
UC and CD, the burden of readmissions is substantial. Over
20% of patients with IBD required a repeat hospitalization
within 90 days of the index admission. These readmissions re-
sulted in a national weighted estimate of over 11 000 excess
hospital days and approximately $107 million total charges in
the pediatric IBD population. Among patients with CD, male
sex and a coexisting diagnosis of anxiety or depression were
associated with significantly increased odds of readmission
within 90 days. In patients with UC, an increased LOS during
the index admission was associated with increased odds of
readmission.
The majority of the literature evaluating risk factors for re-
admission among patients with IBD has evaluated the adult
population. Prior single center studies evaluating adults with
IBD have associated an increased risk of hospital readmis-
sion with factors such as chronic pain and depression.16 Both
anxiety and depression are increased among patients with
IBD compared with other disease states and the general
population.17-19 In addition, anxiety has been associated with
worse outcomes among pediatric patients with IBD20 and
Table IV. Multivariable analysis, odds of readmission








13-17 1.32 (0.94-1.85) 0.89 (0.62-1.28)
Male Sex 1.36 (1.03-1.81) 0.81 (0.58-1.14)
Anxiety or depression 1.89 (1.06-3.40) 1.57 (0.69-3.54)
Index admission to teaching hospital 1.36 (0.80-2.32) 1.32 (0.74-2.37)
Index admission to high volume
IBD center
1.02 (0.70-1.49) 1.27 (0.84-1.92)
Payer/insurance
Medicaid 1.23 (0.92-1.63) 1.19 (0.84-1.69)
Private insurance Reference Reference
Need for IBD-related surgery 0.40 (0.24-0.65) N/A
LOS for index admission (d)
≤3 0.79 (0.57-1.08) 1.05 (0.70-1.57)
4-7 Reference Reference
>7 1.28 (0.87-1.89) 1.69 (1.09-2.62)
*All variables included in the final multivariable analysis are listed above.
Table V. Univariate comparison of characteristics of pediatric patients with UC in the 2013 NRD, including unad-






(95% CI) P valuen % n %
Age (y) .652
≤12 239 32 77 32 Reference
13-17 519 68 165 68 0.86 (0.60-1.24)
Male sex 381 50 116 48 0.78 (0.56-1.10) .109
Anxiety or depression 29 4 14 6 1.66 (0.77-3.54) .123
Index admission to teaching hospital 645 85 224 93 1.73 (1.01-2.95) .005
Index admission to high volume IBD hospital 502 66 196 76 1.46 (1.01-2.12) .045
Payer/insurance .036
Medicaid 256 34 91 38 1.28 (0.91-1.82)
Private insurance 444 59 131 54 Reference
C difficile infection 56 7 11 5 0.52 (0.25-1.10) .088
LOS for index admission (d) .002
≤3 306 40 84 35 1.02 (0.67-1.53)
4-7 275 36 78 32 Reference
>7 177 23 80 33 1.82 (1.18-2.80)
increased resource utilization among adult patients with IBD.21,22
Although the impact of these psychological comorbidities has
been evaluated in multiple studies, a majority of patients with
UC or CD may not receive adequate psychosocial support
in the scheme of their overall treatment for IBD.23 Among
patients with CD in our population, a co-existing diagnosis
of anxiety or depression was associated with readmission within
90 days in both the unadjusted analysis and adjusted analy-
ses. Although the association between a co-existing diagnosis
of anxiety or depression and readmission was not significant
in patients with UC, the magnitude of the effect estimate would
seem to suggest that this relationship may also exist among pa-
tients with UC. Although this study may have been under-
powered to identify a significant relationship, further study of
this potential association is indicated in patients with UC,
as are efforts to better identify and treat psychological
comorbidities among inpatients with IBD.
Among patients with IBD, chronic pain has also been as-
sociated with significant effects on quality of life.24 Less than
11 patients in both populations had a co-existing diagnosis of
chronic pain, and, thus, chronic pain was not used in our analy-
ses of patients with UC or CD. In a study of adult inpatients
with IBD, a diagnosis of CD was associated with increased use
of narcotics despite a lack of association with disease activity
on objective evaluation such as radiographic imaging or
endoscopy.25 Taken together, continued examination of the role
of pain among pediatric patients with IBD seems essential, as
this population was underpowered to evaluate the relation-
ship that chronic pain may play in readmission among pedi-
atric patients with IBD.
In both univariate and multivariable analysis of pediatric
patients with CD, the need for IBD-related surgery was a strong
negative predictor for readmission within 90 days among pe-
diatric patients. This may indicate that surgery offers either a
temporary or definitive successful therapeutic option in pa-
tients with CD, as only 8% of patients requiring an IBD related
surgery during the index admission were readmitted within
90 days. In a prior evaluation of children with CD and intra-
abdominal abscesses, Dotson et al26 found that 64% of pa-
tients with intra-abdominal abscesses treated with medical
management or percutaneous drainage ultimately required sur-
gical intervention within one year. Although preservation of
intestinal length remains a critical focus in pediatric patients
with CD, definitive management with resection in cases of per-
foration and abscess may be key in allowing a patient to resume
school and age appropriate activities more quickly27 while po-
tentially decreasing the risk for readmission.
Among patients with UC, a longer LOS during the index
admission was associated with an increased risk of readmis-
sion within 90 days. Although not significant, we also ob-
served that hospitalization at a teaching hospital seemed to
be associated with increased odds of readmission. We specu-
late that both of these may represent indirect markers of
disease severity. However, the NRD does not contain suffi-
cient clinical data (laboratory data, medication use, or phe-
notypic information) to fully explore the relationships between
disease severity, hospital characteristics, and readmission rates.
The NRD is designed to be a nationally representative sample 
of hospitalizations within the US. However, as the majority of 
hospitalizations are for adult patients, it is unknown whether 
the NRD is truly representative of the entire population of chil-
dren with IBD in the US. Nevertheless, the NRD remains the 
largest, most geographically diverse source of hospitalization 
and readmission data available in the US. There are other limi-
tations in our study as well. As noted, the NRD does not contain 
laboratory data or clinical data regarding the severity of an in-
dividual patient’s disease at the time of hospitalization, and, 
thus, aside from surrogate indicators such as LOS, our ability 
to evaluate the relationship between the severity of disease 
and odds of readmission is limited. Although we evaluated 
variables such as the presence of a fistula or a small bowel ob-
struction, the potential remains that these diagnoses may not 
be coded as accurately as a primary diagnosis of CD.
In addition, the NRD does not contain information on race. 
This is an important limitation given prior literature demon-
strating a shorter time to readmission and a higher probabil-
ity of readmission among black children with IBD when 
compared with white children.11 There is also the potential 
for misclassification of those factors associated with readmis-
sion when using large databases such as the NRD. Because of 
the high likelihood that active IBD is the primary driver of 
many index admissions, the potential exists that comorbid 
conditions such as anxiety, depression, and chronic pain may 
be less likely to be coded. This could lead to an underestima-
tion of the influence that these comorbid diseases have on 
readmission, even when using validated algorithms for case-
finding. We were also  unable to evaluate provider factors that  
may have contributed to readmission, including the impact 
that factors such as early discharge from the index hospital-
ization play in readmission. Although future interest in de-
creasing readmission will likely focus on multidisciplinary 
approaches to discharge planning, a continued focus on pro-
vider decision making during the index hospitalization will 
remain critical in efforts to improve outcomes among hospi-
talized children with IBD.
In conclusion, using a nationwide database, we identified 
a significant economic burden associated with hospital read-
mission among pediatric patients with UC and CD. Among 
patients with CD, psychiatric comorbidities of anxiety or de-
pression and male sex were associated with increased odds of 
readmission within 90 days. Those patients with UC who ex-
perienced longer LOS during their index admission were at in-
creased odds of readmission within 90 days. These findings 
demonstrate the significant economic burden of readmis-
sion in this population and given the paucity of literature evalu-
ating the burden of hospital readmission among children with 
IBD, may lead to future studies to better identify risk factors 
associated with readmission. 
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Table I. ICD-9-CM diagnosis codes used in the analy-
sis of 90-day readmissions among patients with CD and
UC
Diagnoses ICD-9-CM Code
C difficile infection 008.45
Small intestinal resection 45.6×
Colectomy 45.7x, 45.8x
Other abdominal operations 54.xx
Dehydration 276.51
Anemia 280.0, 280.9, 281.9, 285.1, 285.29, 285.9
Depression 296.2, 296.3, 298,0 300.4, 311
Anxiety 300, 300.2
Chronic pain 338.2 or 338.4
Fistula 537.4, 569.81, 619.1
CD 555.xx
UC 556.xx
Intestinal obstruction 560.81, 560.89, 560.9
Abnormal weight loss 783.21
